Article | February 24, 2022

With Many Newer CHO Cell Lines Available, Why Continue To Use The CHO DG44 Variant?

Source: Sartorius
Sartorius BLog

Chinese hamster ovary (CHO) cells are a popular host for the production of biotherapeutics. Their enduring safety record, rapid growth, and ability to generate high product yields make them ideal for the commercial production of a wide range of biologics. There are multiple varieties of CHO cell lines constantly emerging to solve different challenges in the biopharmaceutical industry.

A variety of CHO cell lines are used as hosts in the production of biologics. Each offers unique advantages and is typically tailored to a particular biologic or group of biologics. For example, to enable post-translational modifications or promote the secretion of an extracellular protein. We discuss why we use the CHO DG44 variant for our CHO cell line development platform.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online